Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2010 by Vanak Eye Surgery Center.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Vanak Eye Surgery Center
ClinicalTrials.gov Identifier:
NCT01128699
First received: May 21, 2010
Last updated: NA
Last verified: May 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2011
  Estimated Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)